Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Cresset Corporate Rebrand Reflects New Structure for Growing Company

Cambridge, UK – Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce a corporate rebrand, reflecting a new structure for this growing business.

Read the rest of entry »

Wickham Laboratories Case Study on the Bioburden of the New £5 Polymer Note

Gosport, UK - Wickham Laboratories Ltd is pleased to provide the results of our case study on the bioburden of the new polymer £5 note.

Read the rest of entry »

Dr Darrin Disley speaks at PiR's CEO Breakfast Briefing

Cambridge, UK - PiR was delighted to host senior representatives from the life sciences community, together with the industry trade press, at its CEO Breakfast Forum, which took place at the Chesterford Research Park, Cambridge, United Kingdom on 17 January.

Read the rest of entry »

GFC Diagnostics Wins Global Award for Development of Cheap, Quick and Simple MRSA Test

Chipping Warden, UK - GFC Diagnostics has been awarded one of the three Longitude Prize Discovery Awards awarded to UK organisations for the company’s ground-breaking development of a test which successfully detects antibiotic resistant bacteria, including the superbug MRSA, within 30 minutes.

Read the rest of entry »

Sanifit Announces Enrollment of First Patient in CaLIPSO – a Phase IIb Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialsis

San Diego, USA & Palma, Spain  - Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced that the first patient has been enrolled in the Phase IIb “CaLIPSO Study” clinical trial of lead candidate, SNF472, for the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) patients on haemodialysis (HD).

Read the rest of entry »

Summit Appoints Dr David Roblin as Chief Operating Officer and President of Research & Development

Oxford, UK – Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile infection (‘CDI’), today announces the appointment of Dr David Roblin as Chief Operating Officer (‘COO’) and President of Research and Development.

Read the rest of entry »

AMSBIO Launches New Ready-to-use Adeno-Associated Virus Biosensors

Abingdon, UK - AMSBIO announce a new range of ready-to-use adeno-associated virus (AAV) biosensor products. These viruses encode your chosen biosensor, either calcium or glutamate sensor and are ready for in vivo injection.

Read the rest of entry »

OBN Appoints Mark Hooper as Head of Business Development

Abingdon, UK - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, announced today the appointment of Mark Hooper as the new Head of Business Development with immediate effect.

Read the rest of entry »

Applications Now Open for the The North of England Life Sciences Accelerator

Alderley Park, UK - The North of England Life Sciences Accelerator (NELSA) is looking for early stage businesses & those with a business idea in the life science and healthcare sector.

Read the rest of entry »

SRG Appoints New Director for its Clinical division

Birmingham, UK - Science, clinical and engineering recruitment company SRG has appointed Marianna Suckova as Director of Clinical, based in London.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.